Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes

Journal of Diabetes Research
Magdalena SzopaMaciej T Malecki

Abstract

We previously showed that in HNF1A-MODY the cystatin C-based glomerular filtration rate (GFR) estimate is higher than the creatinine-based estimate. Currently, we aimed to replicate this finding and verify its clinical significance. The study included 72 patients with HNF1A-MODY, 72 with GCK-MODY, 53 with type 1 diabetes (T1DM), 70 with type 2 diabetes (T2DM), and 65 controls. Serum creatinine and cystatin C levels were measured. GFR was calculated from creatinine and cystatin C using the CKD-EPI creatinine equation (eGRF-cr) and CKD-EPI cystatin C equation (eGFR-cys), respectively. Cystatin C levels were lower (p < 0.001) in the control (0.70 ± 0.13 mg/L), HNF1A (0.75 ± 0.21), and GCK (0.72 ± 0.16 mg/L) groups in comparison to those with either T1DM (0.87 ± 0.15 mg/L) or T2DM (0.9 ± 0.23 mg/L). Moreover, eGFR-cys was higher than eGRF-cr in HNF1A-MODY, GCK-MODY, and the controls (p = 0.004; p = 0.003; p < 0.0001). This corresponded to 8.9 mL/min/1.73 m2, 9.7 mL/min/1.73 m2, and 16.9 mL/min/1.73 m2 of difference. Additionally, T1DM patients had higher eGFR-cr than eGFR-cys (11.6 mL/min/1.73 m(2); p = 0.0004); no difference occurred in T2DM (p = 0.91). We confirmed that eGFR-cys values in HNF1A-MODY patients are higher compared t...Continue Reading

References

Mar 28, 2001·EMBO Reports·M PontoglioG Friedlander
Jan 3, 2009·Kidney International·Lesley A StevensAndrew S Levey
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
May 16, 2009·Journal of the American Society of Nephrology : JASN·Toshiharu NinomiyaUNKNOWN ADVANCE Collaborative Group
Jul 10, 2009·Diabetes Care·Ian H de BoerDavid S Siscovick
Sep 3, 2010·American Journal of Physiology. Renal Physiology·Karo TanakaOlivier Devuyst
Nov 10, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·D Z I CherneyB A Perkins
Feb 9, 2012·Clinical Chemistry·Michael A Ferguson, Sushrut S Waikar
Feb 22, 2012·Acta Diabetologica·Natalia NowakMaciej T Malecki
Mar 15, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·S J OhT S Sohn
Jul 6, 2012·The New England Journal of Medicine·Lesley A InkerUNKNOWN CKD-EPI Investigators
Mar 27, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tara I ChangUNKNOWN KEEP Investigators
Apr 27, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Morgan E GramsJosef Coresh
Sep 6, 2013·The New England Journal of Medicine·Michael G ShlipakUNKNOWN CKD Prognosis Consortium
Dec 7, 2013·Journal of the American Society of Nephrology : JASN·Ian H de BoerUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group

❮ Previous
Next ❯

Methods Mentioned

BETA
sample draw

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.